Microfluidic high-throughput 3D cell culture
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Additive Manufacturing and 3D Printing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Dove, A. Screening for content — the evolution of high throughput. Nat. Biotechnol. 21, 859–864 (2003).10.1038/nbt0803-859 ↗
2. Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P. & Tagle, D. A. Organs-on-chips: into the next decade. Nat. Rev. Drug. Discov. 20, 345–361 (2021).10.1038/s41573-020-0079-3 ↗
3. Esch, E. W., Bahinski, A. & Huh, D. Organs-on-chips at the frontiers of drug discovery. Nat. Rev. Drug. Discov. 14, 248–260 (2015).10.1038/nrd4539 ↗
4. Probst, C., Schneider, S. & Loskill, P. High-throughput organ-on-a-chip systems: current status and remaining challenges. Curr. Opin. Biomed. Eng. 6, 33–41 (2018).10.1016/j.cobme.2018.02.004 ↗
5. Schuster, B. et al. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Nat. Commun. 11, 5271 (2020).10.1038/s41467-020-19058-4 ↗
6. van Duinen, V. et al. Perfused 3D angiogenic sprouting in a high-throughput in vitro platform. Angiogenesis 22, 157–165 (2019).10.1007/s10456-018-9647-0 ↗
7. Zhao, Y., Sampson, M. G. & Wen, X. Quantify and control reproducibility in high-throughput experiments. Nat. Methods 17, 1207–1213 (2020).10.1038/s41592-020-00978-4 ↗
8. Zhang, B., Korolj, A., Lai, B. F. L. & Radisic, M. Advances in organ-on-a-chip engineering. Nat. Rev. Mater. 3, 257–278 (2018).10.1038/s41578-018-0034-7 ↗
9. Herbig, M. et al. Best practices for reporting throughput in biomedical research. Nat. Methods 19, 633–634 (2022).10.1038/s41592-022-01483-6 ↗
10. Stresser, D. M. et al. Towards in vitro models for reducing or replacing the use of animals in drug testing. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-023-01154-7 (2023).10.1038/s41551-023-01154-7 ↗
11. Ewart, L. & Roth, A. Opportunities and challenges with microphysiological systems: a pharma end-user perspective. Nat. Rev. Drug. Discov. 20, 327–328 (2021).10.1038/d41573-020-00030-2 ↗
12. Huang, Y. et al. Improving immune–vascular crosstalk for cancer immunotherapy. Nat. Rev. Immunol. 18, 195–203 (2018).10.1038/nri.2017.145 ↗
13. Gao, S., Yang, X., Xu, J., Qiu, N. & Zhai, G. Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the horizons in cancer treatment. ACS nano 15, 12567–12603 (2021).10.1021/acsnano.1c02103 ↗
14. Zhou, Z. et al. Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies. Nat. Rev. Immunol. 24, 18–32 (2023).10.1038/s41577-023-00896-4 ↗
15. Au, S. H. et al. Clusters of circulating tumor cells traverse capillary-sized vessels. Proc. Natl Acad. Sci. USA 113, 4947–4952 (2016).10.1073/pnas.1524448113 ↗
16. Peng, F. et al. Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness. Nat. Nanotechnol. 14, 279–286 (2019).10.1038/s41565-018-0356-z ↗
17. Kim, Y. et al. Quantification of cancer cell extravasation in vivo. Nat. Protoc. 11, 937–948 (2016).10.1038/nprot.2016.050 ↗
18. Park, D. et al. High-throughput microfluidic 3D cytotoxicity assay for cancer immunotherapy (CACI-IMPACT platform). Front. Immunol. 10, 1133 (2019).10.3389/fimmu.2019.01133 ↗
19. Aung, A., Kumar, V., Theprungsirikul, J., Davey, S. K. & Varghese, S. An engineered tumor-on-a-chip device with breast cancer–immune cell interactions for assessing T-cell recruitment. Cancer Res. 80, 263–275 (2020).10.1158/0008-5472.CAN-19-0342 ↗
20. Ayuso, J. M. et al. Microfluidic tumor-on-a-chip model to evaluate the role of tumor environmental stress on NK cell exhaustion. Sci. Adv. 7, eabc2331 (2021).10.1126/sciadv.abc2331 ↗
21. Duval, K. et al. Modeling physiological events in 2D vs. 3D cell culture. Physiology 32, 266–277 (2017).10.1152/physiol.00036.2016 ↗
22. Kim, S., Chung, M., Ahn, J., Lee, S. & Jeon, N. L. Interstitial flow regulates the angiogenic response and phenotype of endothelial cells in a 3D culture model. Lab Chip 16, 4189–4199 (2016).10.1039/C6LC00910G ↗
23. Huh, D. et al. Microfabrication of human organs-on-chips. Nat. Protoc. 8, 2135–2157 (2013).10.1038/nprot.2013.137 ↗
24. Clay, N. E. et al. Modulation of matrix softness and interstitial flow for 3D cell culture using a cell-microenvironment-on-a-chip system. ACS Biomater. Sci. Eng. 2, 1968–1975 (2016).10.1021/acsbiomaterials.6b00379 ↗
25. Shin, J. et al. Monolithic digital patterning of polydimethylsiloxane with successive laser pyrolysis. Nat. Mater. 20, 100–107 (2021).10.1038/s41563-020-0769-6 ↗
26. Homan, K. A. et al. Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat. Methods 16, 255–262 (2019).10.1038/s41592-019-0325-y ↗
27. Herland, A. et al. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips. Nat. Biomed. Eng. 4, 421–436 (2020).10.1038/s41551-019-0498-9 ↗
28. Novak, R. et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat. Biomed. Eng. 4, 407–420 (2020). This article introduces liquid-handling robotics to maintain multiorgan chips for 3 weeks and evaluate drug pharmacodynamics and pharmacokinetics.10.1038/s41551-019-0497-x ↗
29. Lam, J. et al. A microphysiological system-based potency bioassay for the functional quality assessment of mesenchymal stromal cells targeting vasculogenesis. Biomaterials 290, 121826 (2022).10.1016/j.biomaterials.2022.121826 ↗
30. Rajasekar, S. et al. IFlowPlate — a customized 384‐well plate for the culture of perfusable vascularized colon organoids. Adv. Mater. 32, 2002974 (2020). This articles offers an example of achieving both biological relevance and high throughput by using organoids and a standard well-plate format.10.1002/adma.202002974 ↗
31. Ao, Z. et al. Microfluidics guided by deep learning for cancer immunotherapy screening. Proc. Natl Acad. Sci. USA 119, e2214569119 (2022).10.1073/pnas.2214569119 ↗
32. Bhatia, S. N. & Ingber, D. E. Microfluidic organs-on-chips. Nat. Biotechnol. 32, 760–772 (2014).10.1038/nbt.2989 ↗
33. Vunjak-Novakovic, G., Ronaldson-Bouchard, K. & Radisic, M. Organs-on-a-chip models for biological research. Cell 184, 4597–4611 (2021).10.1016/j.cell.2021.08.005 ↗
34. Ingber, D. E. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat. Rev. Genet. 23, 467–491 (2022).10.1038/s41576-022-00466-9 ↗
35. Ma, C., Peng, Y., Li, H. & Chen, W. Organ-on-a-chip: a new paradigm for drug development. Trends Pharmacol. Sci. 42, 119–133 (2021).10.1016/j.tips.2020.11.009 ↗
36. Wang, Y. & Jeon, H. 3D cell cultures toward quantitative high-throughput drug screening. Trends Pharmacol. Sci. 43, 569–581 (2022).10.1016/j.tips.2022.03.014 ↗
37. Pan, C., Kumar, C., Bohl, S., Klingmueller, U. & Mann, M. Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions. Mol. Cell. Proteom. 8, 443–450 (2009).10.1074/mcp.M800258-MCP200 ↗
38. Hashemzadeh, H. et al. A combined microfluidic deep learning approach for lung cancer cell high throughput screening toward automatic cancer screening applications. Sci. Rep. 11, 9804 (2021).10.1038/s41598-021-89352-8 ↗
39. Wang, Y., Wang, L., Guo, Y., Zhu, Y. & Qin, J. Engineering stem cell-derived 3D brain organoids in a perfusable organ-on-a-chip system. RSC Adv. 8, 1677–1685 (2018).10.1039/C7RA11714K ↗
40. Huebsch, N. et al. Metabolically driven maturation of human-induced-pluripotent-stem-cell-derived cardiac microtissues on microfluidic chips. Nat. Biomed. Eng. 6, 372–388 (2022).10.1038/s41551-022-00884-4 ↗
41. Sances, S. et al. Human iPSC-derived endothelial cells and microengineered organ-chip enhance neuronal development. Stem Cell Rep. 10, 1222–1236 (2018).10.1016/j.stemcr.2018.02.012 ↗
42. Zheng, Y., Shao, Y. & Fu, J. A microfluidics-based stem cell model of early post-implantation human development. Nat. Protoc. 16, 309–326 (2021).10.1038/s41596-020-00417-w ↗
43. Zheng, Y. et al. Controlled modelling of human epiblast and amnion development using stem cells. Nature 573, 421–425 (2019).10.1038/s41586-019-1535-2 ↗
44. Lei, Y. & Schaffer, D. V. A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc. Natl Acad. Sci. USA 110, E5039–E5048 (2013).10.1073/pnas.1309408110 ↗
45. Vatine, G. D. et al. Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications. Cell Stem Cell 24, 995–1005 (2019). This article describes a blood–brain barrier based on iPS-cell-derived endothelial cells, with enhanced barrier function induced by shear flow and coculture.10.1016/j.stem.2019.05.011 ↗
46. Hu, Y. et al. Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week. Nat. Commun. 12, 2581 (2021).10.1038/s41467-021-22676-1 ↗
47. Shirure, V. S. et al. Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. Lab Chip 18, 3687–3702 (2018).10.1039/C8LC00596F ↗
48. Lai, B. F. L. et al. Recapitulating pancreatic tumor microenvironment through synergistic use of patient organoids and organ‐on‐a‐chip vasculature. Adv. Funct. Mater. 30, 2000545 (2020).10.1002/adfm.202000545 ↗
49. Kratochvil, M. J. et al. Engineered materials for organoid systems. Nat. Rev. Mater. 4, 606–622 (2019).10.1038/s41578-019-0129-9 ↗
50. Garreta, E. et al. Rethinking organoid technology through bioengineering. Nat. Mater. 20, 145–155 (2021).10.1038/s41563-020-00804-4 ↗
51. Kim, S.-J., Kim, E. M., Yamamoto, M., Park, H. & Shin, H. Engineering multi-cellular spheroids for tissue engineering and regenerative medicine. Adv. Healthc. Mater. 9, 2000608 (2020).10.1002/adhm.202000608 ↗
52. Kang, S.-M., Kim, D., Lee, J.-H., Takayama, S. & Park, J. Y. Engineered microsystems for spheroid and organoid studies. Adv. Healthc. Mater. 10, 2001284 (2021).10.1002/adhm.202001284 ↗
53. Hofer, M. & Lutolf, M. P. Engineering organoids. Nat. Rev. Mater. 6, 402–420 (2021).10.1038/s41578-021-00279-y ↗
54. Lee, H. N. et al. Effect of biochemical and biomechanical factors on vascularization of kidney organoid-on-a-chip. Nano Converg. 8, 35 (2021).10.1186/s40580-021-00285-4 ↗
55. Bonanini, F. et al. In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed. Angiogenesis 25, 455–470 (2022).10.1007/s10456-022-09842-9 ↗
56. Prince, E. et al. Microfluidic arrays of breast tumor spheroids for drug screening and personalized cancer therapies. Adv. Healthc. Mater. 11, 2101085 (2022).10.1002/adhm.202101085 ↗
57. Nashimoto, Y. et al. Vascularized cancer on a chip: the effect of perfusion on growth and drug delivery of tumor spheroid. Biomaterials 229, 119547 (2020).10.1016/j.biomaterials.2019.119547 ↗
58. Haase, K., Offeddu, G. S., Gillrie, M. R. & Kamm, R. D. Endothelial regulation of drug transport in a 3D vascularized tumor model. Adv. Funct. Mater. 30, 2002444 (2020).10.1002/adfm.202002444 ↗
59. Seiler, S. T. et al. Modular automated microfluidic cell culture platform reduces glycolytic stress in cerebral cortex organoids. Sci. Rep. 12, 20173 (2022).10.1038/s41598-022-20096-9 ↗
60. Salmon, I. et al. Engineering neurovascular organoids with 3D printed microfluidic chips. Lab Chip 22, 1615–1629 (2022).10.1039/D1LC00535A ↗
61. Cho, A.-N. et al. Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids. Nat. Commun. 12, 4730 (2021).10.1038/s41467-021-24775-5 ↗
62. Byrne, A. T. et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat. Rev. Cancer 17, 254–268 (2017).10.1038/nrc.2016.140 ↗
63. Dobrolecki, L. E. et al. Patient-derived xenograft (PDX) models in basic and translational breast cancer research. Cancer Metastasis Rev. 35, 547–573 (2016).10.1007/s10555-016-9653-x ↗
64. Mathur, T., Tronolone, J. J. & Jain, A. Comparative analysis of blood‐derived endothelial cells for designing next‐generation personalized organ‐on‐chips. J. Am. Heart Assoc. 10, e022795 (2021).10.1161/JAHA.121.022795 ↗
65. Pediaditakis, I. et al. Modeling alpha-synuclein pathology in a human brain-chip to assess blood–brain barrier disruption. Nat. Commun. 12, 5907 (2021).10.1038/s41467-021-26066-5 ↗
66. Park, T.-E. et al. Hypoxia-enhanced blood–brain barrier chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat. Commun. 10, 2621 (2019).10.1038/s41467-019-10588-0 ↗
67. Ibrahim, lI., Hajal, C., Offeddu, G. S., Gillrie, M. R. & Kamm, R. D. Omentum-on-a-chip: a multicellular, vascularized microfluidic model of the human peritoneum for the study of ovarian cancer metastases. Biomaterials 288, 121728 (2022).10.1016/j.biomaterials.2022.121728 ↗
68. Zhao, J. et al. Separation and single-cell analysis for free gastric cancer cells in ascites and peritoneal lavages based on microfluidic chips. Ebiomedicine 90, 104522 (2023).10.1016/j.ebiom.2023.104522 ↗
69. Hyung, S. et al. Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer. Sci. Adv. 9, eadk1098 (2023).10.1126/sciadv.adk1098 ↗
70. Schwab, F. D. et al. MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies. Microsyst. Nanoeng. 8, 130 (2022).10.1038/s41378-022-00467-y ↗
71. Descamps, L. et al. MagPure chip: an immunomagnetic-based microfluidic device for high purification of circulating tumor cells from liquid biopsies. Lab Chip 22, 4151–4166 (2022).10.1039/D2LC00443G ↗
72. Meran, L., Tullie, L., Eaton, S., De Coppi, P. & Li, V. S. Bioengineering human intestinal mucosal grafts using patient-derived organoids, fibroblasts and scaffolds. Nat. Protoc. 18, 108–135 (2023).10.1038/s41596-022-00751-1 ↗
73. Phifer, C. J. et al. Obtaining patient-derived cancer organoid cultures via fine-needle aspiration. STAR. Protoc. 2, 100220 (2021).10.1016/j.xpro.2020.100220 ↗
74. Huang, L. et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell–and patient-derived tumor organoids. Nat. Med. 21, 1364–1371 (2015).10.1038/nm.3973 ↗
75. Lou, J. & Mooney, D. J. Chemical strategies to engineer hydrogels for cell culture. Nat. Rev. Chem. 6, 726–744 (2022).10.1038/s41570-022-00420-7 ↗
76. Jiménez, G. et al. A soft 3D polyacrylate hydrogel recapitulates the cartilage niche and allows growth-factor free tissue engineering of human articular cartilage. Acta Biomater. 90, 146–156 (2019).10.1016/j.actbio.2019.03.040 ↗
77. Son, K. J., Gheibi, P., Stybayeva, G., Rahimian, A. & Revzin, A. Detecting cell-secreted growth factors in microfluidic devices using bead-based biosensors. Microsyst. Nanoeng. 3, 1–9 (2017).10.1038/micronano.2017.25 ↗
78. Clancy, A. et al. Hydrogel-based microfluidic device with multiplexed 3D in vitro cell culture. Sci. Rep. 12, 17781 (2022).10.1038/s41598-022-22439-y ↗
79. Burdick, J. A. & Murphy, W. L. Moving from static to dynamic complexity in hydrogel design. Nat. Commun. 3, 1269 (2012).10.1038/ncomms2271 ↗
80. Akther, F., Little, P., Li, Z., Nguyen, N.-T. & Ta, H. T. Hydrogels as artificial matrices for cell seeding in microfluidic devices. RSC Adv. 10, 43682–43703 (2020).10.1039/D0RA08566A ↗
81. Han, S. et al. Hydrophobic patterning‐based 3D microfluidic cell culture assay. Adv. Healthc. Mater. 7, 1800122 (2018).10.1002/adhm.201800122 ↗
82. Angelidakis, E. et al. Impact of fibrinogen, fibrin thrombi and thrombin on cancer cell extravasation using in vitro microvascular networks. Adv. Healthc. Mater. 12, 2202984 (2023).10.1002/adhm.202202984 ↗
83. Bang, S., Na, S., Jang, J. M., Kim, J. & Jeon, N. L. Engineering‐aligned 3D neural circuit in microfluidic device. Adv. Healthc. Mater. 5, 159–166 (2016).10.1002/adhm.201500397 ↗
84. Fridman, I. B. et al. High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment. Acta Biomater. 132, 473–488 (2021).10.1016/j.actbio.2021.06.025 ↗
85. Kwak, T. J. & Lee, E. In vitro modeling of solid tumor interactions with perfused blood vessels. Sci. Rep. 10, 20142 (2020).10.1038/s41598-020-77180-1 ↗
86. Kim, S., Lee, H., Chung, M. & Jeon, N. L. Engineering of functional, perfusable 3D microvascular networks on a chip. Lab Chip 13, 1489–1500 (2013).10.1039/c3lc41320a ↗
87. Shin, Y. et al. Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels. Nat. Protoc. 7, 1247–1259 (2012).10.1038/nprot.2012.051 ↗
88. Berthier, E., Dostie, A. M., Lee, U. N., Berthier, J. & Theberge, A. B. Open microfluidic capillary systems. Anal. Chem. 91, 8739–8750 (2019). This article discusses open microfluidic platforms that can provide variable configurations of cell layout and high throughput.10.1021/acs.analchem.9b01429 ↗
89. Berry, S. B. et al. Upgrading well plates using open microfluidic patterning. Lab Chip 17, 4253–4264 (2017).10.1039/C7LC00878C ↗
90. Huang, C. P. et al. Engineering microscale cellular niches for three-dimensional multicellular co-cultures. Lab Chip 9, 1740–1748 (2009).10.1039/b818401a ↗
91. Lee, Y. et al. Microfluidics within a well: an injection-molded plastic array 3D culture platform. Lab Chip 18, 2433–2440 (2018). This article describes the methodology for designing injection-moulded microfluidic devices with open microfluidic analysis and 3D-printed prototyping.10.1039/C8LC00336J ↗
92. Chaudhuri, O. et al. Hydrogels with tunable stress relaxation regulate stem cell fate and activity. Nat. Mater. 15, 326–334 (2016).10.1038/nmat4489 ↗
93. Rosales, A. M. & Anseth, K. S. The design of reversible hydrogels to capture extracellular matrix dynamics. Nat. Rev. Mater. 1, 15012 (2016).10.1038/natrevmats.2015.12 ↗
94. Hudalla, G. A. & Murphy, W. L. Biomaterials that regulate growth factor activity via bioinspired interactions. Adv. Funct. Mater. 21, 1754–1768 (2011).10.1002/adfm.201002468 ↗
95. Kumachev, A. et al. High-throughput generation of hydrogel microbeads with varying elasticity for cell encapsulation. Biomaterials 32, 1477–1483 (2011).10.1016/j.biomaterials.2010.10.033 ↗
96. Arık, Y. B. et al. Collagen I based enzymatically degradable membranes for organ-on-a-chip barrier models. ACS Biomater. Sci. Eng. 7, 2998–3005 (2021).10.1021/acsbiomaterials.0c00297 ↗
97. Mondrinos, M. J., Yi, Y.-S., Wu, N.-K., Ding, X. & Huh, D. Native extracellular matrix-derived semipermeable, optically transparent, and inexpensive membrane inserts for microfluidic cell culture. Lab Chip 17, 3146–3158 (2017).10.1039/C7LC00317J ↗
98. Humayun, M., Chow, C.-W. & Young, E. W. K. Microfluidic lung airway-on-a-chip with arrayable suspended gels for studying epithelial and smooth muscle cell interactions. Lab Chip 18, 1298–1309 (2018).10.1039/C7LC01357D ↗
99. Park, J. Y. et al. A microphysiological model of human trophoblast invasion during implantation. Nat. Commun. 13, 1252 (2022).10.1038/s41467-022-28663-4 ↗
100. Park, S. E., Georgescu, A., Oh, J. M., Kwon, K. W. & Huh, D. Polydopamine-based interfacial engineering of extracellular matrix hydrogels for the construction and long-term maintenance of living three-dimensional tissues. ACS Appl. Mater. Interfaces 11, 23919–23925 (2019).10.1021/acsami.9b07912 ↗